DSE : IBNSINA

The IBN SINA Pharmaceutical Industry PLC — Financial statements

Pharmaceutical Preparations · Bangladesh

Last price 293.2 BDT (At close: Oct 29, 2026) · Market cap 9.16B

Latest research: IBN SINA Pharmaceutical financial analysis: 18% 9M sales growth, Mawna plant capex and record 77% dividend (Oct 2026) · IBN SINA Pharmaceutical: 9M FY2026 sales up 18% as the Mawna plant lifts capital work-in-progress to BDT 4.1bn, funded mostly with debt

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Financial statements

The IBN SINA Pharmaceutical Industry PLC (IBNSINA) reported revenue of 13.48B BDT (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue13.48B11.88B11.37B9.13B8.48B7.38B
Cost of Revenue7.97B7.08B6.84B5.25B4.91B4.28B
Gross Profit5.51B4.80B4.53B3.87B3.57B3.10B
Selling, General & Admin4.41B3.90B3.62B3.05B2.74B2.37B
Operating Expenses4.41B3.90B3.62B3.05B2.74B2.37B
Operating Income1.10B902.17M914.57M819.81M821.16M732.91M
Interest Expense-117.92M-87.40M-53.58M-44.43M-47.33M-40.00M
Interest & Investment Income3.08M3.08M4.13M2.37M3.33M2.46M
Earnings From Equity Investments-1.29M-1.93M
Currency Exchange Gain (Loss)1.22M1.22M7.26M11.15M-2.83M-199.34K
Other Non Operating Income (Expenses)28.53M20.55M21.95M13.59M17.22M9.99M
EBT Excluding Unusual Items1.02B839.61M894.34M802.50M790.27M703.23M
Gain (Loss) on Sale of Investments9.60M
Gain (Loss) on Sale of Assets359.79K359.79K359.79K2.23M1.22M
Pretax Income1.02B839.97M894.70M804.73M799.86M704.45M
Income Tax Expense229.61M206.72M223.35M198.92M194.19M215.48M
Earnings From Continuing Operations786.89M633.26M671.35M605.81M605.67M488.97M
Minority Interest in Earnings1.46M-66.88K-828.35K-392.18K192.39K151.62K
Net Income788.34M633.19M670.52M605.42M605.87M489.12M
Net Income to Common788.34M633.19M670.52M605.42M605.87M489.12M
Shares Outstanding (Basic)31.24M31.24M31.24M31.24M31.24M31.24M
Shares Outstanding (Diluted)31.24M31.24M31.24M31.24M31.24M31.24M
EPS (Basic)25.2320.2721.4619.3819.3915.66
EPS (Diluted)25.2320.2721.4619.3819.3915.66
Free Cash Flow-1.73B-257.82M-556.90M472.99M53.40M309.64M
Free Cash Flow Per Share-55.22-8.25-17.8215.141.719.91
Dividend Per Share6.406.406.306.006.004.70
Gross Margin40.88%40.39%39.85%42.42%42.05%42.04%
Operating Margin8.17%7.59%8.04%8.98%9.68%9.94%
Profit Margin5.85%5.33%5.90%6.63%7.14%6.63%
Free Cash Flow Margin-12.80%-2.17%-4.90%5.18%0.63%4.20%
EBITDA1.27B1.09B1.09B1.56B1.02B922.15M
EBITDA Margin9.46%9.15%9.61%17.07%12.04%12.50%
D&A For EBITDA173.07M185.55M178.12M738.18M199.57M189.24M
EBIT1.10B902.17M914.57M819.81M821.16M732.91M
EBIT Margin8.17%7.59%8.04%8.98%9.68%9.94%
Effective Tax Rate22.59%24.61%24.96%24.72%24.28%30.59%
Advertising Expenses65.83M63.23M51.87M47.72M42.36M

Balance sheet

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents335.07M314.90M365.23M232.23M342.61M281.24M
Short-Term Investments42.66M22.50M166.79M
Cash & Short-Term Investments377.73M337.40M532.02M232.23M342.61M281.24M
Accounts Receivable286.18M189.86M195.83M96.10M43.61M23.61M
Other Receivables2.91M6.19M6.69M11.03M10.22M3.66M
Receivables289.09M196.05M202.51M107.13M53.83M27.27M
Inventory1.88B1.81B1.59B1.16B1.01B782.16M
Other Current Assets656.91M503.71M300.44M340.44M232.54M367.16M
Total Current Assets3.20B2.85B2.62B1.84B1.64B1.46B
Property, Plant & Equipment6.68B4.62B3.83B3.10B2.60B2.33B
Long-Term Investments41.17M46.66M54.17M57.22M56.11M56.87M
Other Long-Term Assets17.57M33.72M9.05M8.80M21.66M
Total Assets9.94B7.55B6.51B5.01B4.31B3.85B
Accounts Payable578.62M396.18M260.30M282.31M166.18M231.65M
Accrued Expenses367.04M246.61M249.51M218.04M97.59M137.68M
Short-Term Debt2.19B953.68M1.24B512.14M534.29M377.50M
Current Portion of Long-Term Debt89.58M119.45M62.30M72.21M70.18M65.16M
Current Portion of Leases2.59M23.80M25.54M22.41M22.06M2.37M
Current Income Taxes Payable687.49M495.25M284.58M212.06M165.56M279.30M
Other Current Liabilities177.64M241.60M193.32M142.30M68.17M61.62M
Total Current Liabilities4.10B2.48B2.32B1.46B1.12B1.16B
Long-Term Debt1.29B974.71M530.49M330.09M368.01M419.62M
Long-Term Leases24.80M51.34M74.75M1.99M
Pension & Post-Retirement Benefits2.34M990.55K1.19M1.01M734.70K94.03K
Long-Term Deferred Tax Liabilities104.90M96.46M101.18M105.81M117.72M118.87M
Other Long-Term Liabilities1.001.00-1.00
Total Liabilities5.49B3.55B2.98B1.95B1.69B1.70B
Common Stock312.44M312.44M312.44M312.44M312.44M312.44M
Retained Earnings4.05B3.63B3.19B2.71B2.29B1.83B
Comprehensive Income & Other-20.48M-15.54M-8.61M-2.27M-685.59K145.09K
Total Common Equity4.35B3.93B3.50B3.02B2.60B2.15B
Minority Interest104.81M70.95M35.88M35.05M20.66M3.35M
Shareholders' Equity4.45B4.00B3.53B3.06B2.63B2.15B
Total Liabilities & Equity9.94B7.55B6.51B5.01B4.31B3.85B
Total Debt3.57B2.07B1.89B988.19M1.07B866.65M
Net Cash (Debt)-3.18B-1.72B-1.33B-723.75M-695.57M-580.23M
Net Cash Per Share-101.87-54.94-42.52-23.16-22.26-18.57
Filing Date Shares Outstanding31.24M31.24M31.24M31.24M31.24M31.24M
Total Common Shares Outstanding31.24M31.24M31.24M31.24M31.24M31.24M
Working Capital-895.74M368.68M302.22M374.96M512.52M302.55M
Book Value Per Share139.10125.69111.9496.6883.3668.69
Tangible Book Value4.35B3.93B3.50B3.02B2.60B2.15B
Tangible Book Value Per Share139.10125.69111.9496.6883.3668.69
Construction In Progress4.09B1.93B1.14B572.47M144.25M111.41M

Cash flow statement

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income788.34M633.19M670.52M605.87M489.12M
Depreciation & Amortization216.47M210.36M203.11M764.54M223.93M215.86M
Loss (Gain) From Sale of Assets-359.79K11.15M1.22M
Loss (Gain) on Equity Investments-11.91M1.29M1.93M
Other Operating Activities-119.75M-63.56M-29.79M52.15M-61.17M-59.61K
Change in Accounts Receivable-20.29M-20.29M-46.97M-66.51M-26.55M-1.93M
Change in Inventory-222.74M-222.74M-428.70M-3.15M-225.40M-138.78M
Change in Accounts Payable234.18M234.18M-22.01M141.75M-95.77M-10.05M
Change in Other Net Operating Assets-47.47M-47.47M44.11M10.16M-3.62M-5.14M
Operating Cash Flow828.75M723.68M389.91M898.18M418.56M552.17M
Capital Expenditures-2.55B-981.50M-946.81M-425.19M-365.16M-242.53M
Sale of Property, Plant & Equipment422.50K2.55M1.43M
Investment in Securities57.77M142.99M-67.00M-196.36M60.00M-3.00M
Other Investing Activities6.20M9.67M8.21M2.51M2.86M2.07M
Investing Cash Flow-2.49B-828.84M-1.01B-616.49M-302.30M-242.03M
Short-Term Debt Issued720.50M159.44M
Long-Term Debt Issued444.21M200.40M171.70M
Total Debt Issued1.58B444.21M920.90M159.44M171.70M
Short-Term Debt Repaid-231.73M-137.72M-272.31M
Long-Term Debt Repaid-37.92M-51.61M
Total Debt Repaid181.19M-231.73M-175.64M-51.61M-272.31M
Net Debt Issued (Repaid)1.76B212.49M920.90M-175.64M107.82M-100.61M
Common Dividends Paid-224.29M-193.87M-179.90M-178.52M-177.39M-131.51M
Other Financing Activities60.00M35.00M17.50M3.50M
Financing Cash Flow1.59B53.62M741.00M-354.16M-52.07M-228.62M
Foreign Exchange Rate Adjustments9.79M1.22M7.26M11.15M-2.83M-199.34K
Miscellaneous Cash Flow Adjustments1.001.001.00
Net Cash Flow-58.71M-50.33M133.00M-61.32M61.37M81.32M
Free Cash Flow-1.73B-257.82M-556.90M472.99M53.40M309.64M
Free Cash Flow Margin-12.80%-2.17%-4.90%5.18%0.63%4.20%
Free Cash Flow Per Share-55.22-8.25-17.8215.141.719.91
Levered Free Cash Flow-1.81B-289.52M-556.67M870.90M12.31M230.82M
Unlevered Free Cash Flow-1.74B-234.89M-523.18M898.67M41.89M255.82M
Cash Interest Paid83.71M83.71M47.77M36.61M40.94M38.76M
Cash Income Tax Paid180.79M180.67M203.58M131.83M216.77M186.64M
Change in Working Capital-56.31M-56.31M-453.57M82.25M-351.35M-155.90M

Ratios

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization9.16B9.19B7.80B8.95B9.27B7.71B
Enterprise Value13.01B10.67B8.92B9.69B9.89B8.40B
Last Close Price293.20287.80239.44268.97272.99223.17
PE Ratio11.5314.5111.6414.7915.3015.76
Forward PE12.7310.2412.68
PS Ratio0.660.770.690.981.091.04
PB Ratio1.972.302.212.933.533.59
P/TBV Ratio2.032.342.232.963.563.59
P/FCF Ratio18.93173.5924.89
P/OCF Ratio7.7312.7020.029.9722.1513.96
EV/Sales Ratio0.940.900.781.061.171.14
EV/EBITDA Ratio9.929.818.166.229.699.11
EV/EBIT Ratio11.7511.829.7511.8212.0511.46
EV/FCF Ratio20.49185.2527.12
Debt / Equity Ratio0.800.520.530.320.410.40
Debt / EBITDA Ratio2.751.861.690.621.020.91
Debt / FCF Ratio2.0920.022.80
Net Debt / Equity Ratio0.710.430.380.240.270.27
Net Debt / EBITDA Ratio2.501.581.220.470.680.63
Net Debt / FCF Ratio-1.84-6.66-2.391.5313.031.87
Asset Turnover1.571.691.981.962.082.03
Inventory Turnover4.454.174.994.865.496.00
Quick Ratio0.160.210.320.230.350.27
Current Ratio0.781.151.131.261.461.26
Return on Equity (ROE)18.99%16.82%20.38%21.33%25.37%24.91%
Return on Assets (ROA)8.01%8.02%9.93%11.00%12.59%12.58%
Return on Invested Capital (ROIC)11.83%12.81%15.78%17.23%20.43%19.27%
Return on Capital Employed (ROCE)18.80%17.80%21.80%23.10%25.80%27.20%
Earnings Yield8.67%6.89%8.59%6.76%6.54%6.35%
FCF Yield-20.17%-2.81%-7.13%5.28%0.58%4.02%
Dividend Yield2.63%2.18%2.52%2.09%2.02%1.91%
Payout Ratio26.93%30.62%26.83%29.49%29.28%26.89%
Total Shareholder Return2.63%2.18%2.52%2.09%2.02%1.91%